The heme-regulated eukaryotic initiation factor 2␣ (eIF2␣) kinase (heme-regulated inhibitor (HRI)) is activated by heme deficiency in reticulocytes and plays an important role in translational control in these cells. Previously, HRI was cloned from rabbit reticulocytes and rat brain, but a heme-regulated eIF2␣ kinase activity has only been purified from erythroid cells. In this study, we report the purification of a heme-sensitive eIF2␣ kinase activity from both mouse liver and NIH 3T3 cell extracts. Furthermore, we have cloned and characterized this mouse liver eIF2␣ kinase (mHRI), which exhibits 83 and 94% identities to rabbit and rat HRIs, respectively. Both the purified enzyme and recombinant mHRI exhibited an autokinase and an eIF2␣ kinase activity, and both activities were inhibited in vitro by hemin. In addition, wild-type mHRI, but not the inactive mHRI-K196R mutant, was autophosphorylated in vivo when it was expressed in 293 cells. Quantitation of mHRI mRNA expression in various mouse tissues by reverse transcription-polymerase chain reaction revealed relatively high levels in liver, kidney, and testis. These results provide strong evidence that mHRI is a ubiquitous eIF2␣ kinase of mammalian cells, suggesting that it could play important roles in the translational regulation of nonerythroid tissues.
The heme-regulated eukaryotic initiation factor 2␣ (eIF2␣) kinase (heme-regulated inhibitor (HRI)) is activated by heme deficiency in reticulocytes and plays an important role in translational control in these cells. Previously, HRI was cloned from rabbit reticulocytes and rat brain, but a heme-regulated eIF2␣ kinase activity has only been purified from erythroid cells. In this study, we report the purification of a heme-sensitive eIF2␣ kinase activity from both mouse liver and NIH 3T3 cell extracts. Furthermore, we have cloned and characterized this mouse liver eIF2␣ kinase (mHRI), which exhibits 83 and 94% identities to rabbit and rat HRIs, respectively. Both the purified enzyme and recombinant mHRI exhibited an autokinase and an eIF2␣ kinase activity, and both activities were inhibited in vitro by hemin. In addition, wild-type mHRI, but not the inactive mHRI-K196R mutant, was autophosphorylated in vivo when it was expressed in 293 cells. Quantitation of mHRI mRNA expression in various mouse tissues by reverse transcription-polymerase chain reaction revealed relatively high levels in liver, kidney, and testis. These results provide strong evidence that mHRI is a ubiquitous eIF2␣ kinase of mammalian cells, suggesting that it could play important roles in the translational regulation of nonerythroid tissues.
Phosphorylation of the ␣-subunit of eukaryotic initiation factor 2 (eIF2␣) 1 is one of the best characterized mechanisms for down-regulating protein synthesis in mammalian cells in response to various stress conditions (for reviews, see Refs. [1] [2] [3] [4] . The phosphorylation of eIF2␣ was first detected in rabbit reticulocyte lysates deprived of hemin. The absence of hemin results in the activation of a highly specific eIF2␣ kinase called the heme-regulated inhibitor (HRI) (1, 5) . Another mammalian eIF2␣ kinase, the double-stranded RNA-activated kinase PKR, is constitutively expressed in reticulocytes and inducible by interferon in other mammalian cells (6) . At present, only these two distinct mammalian eIF2␣ kinases have been cloned (5, 6) . A third eIF2␣ kinase, termed GCN2, has been characterized from Saccharomyces cerevisiae (7) and from Drosophila melanogaster (8) . It is activated by uncharged tRNA in response to amino acid starvation in yeast (7) .
All three of the known eIF2␣ kinases share significant homology in the catalytic domains (9) and phosphorylate eIF2␣ at serine 51. This phosphorylation mediates translational control by reducing the levels of functional eIF2B, which is required for the exchange of GTP for GDP in the recycling of eIF2 (1, 10) . Although phosphorylation of eIF2␣ was believed to nonspecifically down-regulate translation initiation, recent results have indicated that it can up-regulate the synthesis of specific proteins (4, 11) . Thus, eIF2␣ phosphorylation enhances the translation of yeast GCN4, a transcriptional activator of genes involved in the biosynthesis of amino acids (4, 7) .
Previous studies suggest a role for eIF2␣ phosphorylation in the control of cell growth and differentiation (11, 12) . They mostly concerned PKR, but the significant homology of HRI to three yeast protein kinases implicated in the regulation of the cell cycle (13) and the fact that HRI, as well as PKR, functionally exchanges for GCN2 in the GCN4 translational control of yeast (14) raise the possibility of additional roles for HRI and GCN2 in the regulation of cellular fate in response to stress conditions or growth factors (11, 12) .
HRI cDNA has been cloned from rabbit reticulocytes (13) and rat brain (15) , showing 82% amino acid identity. Both rabbit and rat HRIs contain two heme regulatory motifs located within the catalytic domain and not found in either PKR or GCN2 (5, 11) . Although a role for HRI has been clearly defined in reticulocytes, the tissue specificity of HRI expression remains uncertain (11, 12) . To date, little is known about eIF2␣ kinases in nonerythroid cells other than PKR, and as Chen and London (5) noted, a hemin-sensitive eIF2␣ kinase activity has not been well characterized in nonerythroid tissues. In fact, it has been proposed that neither the HRI mRNA nor the HRI protein is expressed in nonerythroid cells (16, 17) . Although, Mellor et al. (15) have found the HRI mRNA in a wide range of nonerythroid rat tissues, it remains to be determined whether there are HRI-like enzymes in nonerythroid cells.
In this paper, we report an eIF2␣ kinase activity that has been purified from either mouse liver or NIH 3T3 cell extracts and that has shown the same sensitivity to hemin treatment as did HRI purified from rabbit reticulocytes. In addition, we report the cloning of mouse liver HRI (mHRI) and, subsequently, the finding that the corresponding mRNA is present in several nonerythroid tissues and in NIH 3T3 cells. Also, we present evidence that mHRI is active as an autokinase and as an eIF2␣ kinase and that both activities are responsive to hemin in vitro. When expressed in 293 cells, wild-type mHRI, but not the inactive mHRI-K196R mutant, is autophosphoryl-* This work was supported by Grant BI04-CT95-0045 from the European Commission Directorate General XII Biotechnology Program and by an institutional grant from the Fundación Ramón Areces (to the Centro de Biología Molecular "Severo Ochoa"). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBank TM /EBI Data Bank with accession number(s) AF028808.
‡ To whom correspondence and reprint requests should be addressed. Tel.: 34-91-397-8432; Fax: 34-91-397-4799; E-mail: cdeharo@cbm. uam.es. 1 The abbreviations used are: eIF2␣, the ␣-subunit (38 kDa) of eukaryotic polypeptide chain initiation factor 2; HRI, heme-regulated inhibitor; mHRI, mouse liver heme-regulated inhibitor; TEMED, N,N,NЈ,NЈ-tetramethylethylenediamine; RT-PCR, reverse transcription-polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis.
ated in vivo. This study provides evidence for the first time that HRI is expressed as an active protein kinase in nonerythroid mammalian cells and opens the possibility of broader participation of this eIF2␣ kinase in translational control.
EXPERIMENTAL PROCEDURES
Materials and Preparations-All reagents were from Sigma except as follows. DEAE-cellulose (DE52) was from Whatman BioSystems Ltd. Heparin-Sepharose, Mono Q HR 5/5, protein A-Sepharose, and ammonium persulfate were from Amersham Pharmacia Biotech. Acrylamide, N,NЈ-methylenebisacrylamide, TEMED, and SDS were obtained from Bio-Rad. The high pressure liquid chromatography-purified synthetic peptide CLLAELS 51 RRRIRAIN (eIF2 peptide), corresponding to amino acids 46 -59 of eIF2␣, but with two alanine residues instead of Ser-48 and Ser-57 and with an additional cysteine residue at its NH 2 -terminal end, was obtained from Med Probe A. S. (Oslo, Norway). Specific DNA primers were obtained from Isogen Bioscience. Rabbit reticulocyte lysates, anti-HRI peptide antibodies, highly purified reticulocyte eIF2, and partially purified heme-reversible HRI were obtained as described previously (18, 19) .
Purification of an eIF2␣ Kinase Activity from Mouse Liver ExtractsAll operations were performed at 0 -4°C. Livers were removed from freshly killed young BALB/c mice (6 -8 weeks old), placed into ice-cold lysis buffer (70 mM Hepes/KOH (pH 7.6), 150 mM KCl, 1 mM EGTA, and 1 mM dithiothreitol), rinsed extensively in this buffer, and then chopped finely to wash out blood and fur. The tissue was homogenized in the same ice-cold buffer with a Polytron (Brinkmann Instruments). The lysate was clarified by centrifugation for 10 min at 27,000 ϫ g. Following centrifugation for 1 h at 100,000 ϫ g, the top two-thirds of the supernatant were collected, taking care not to pick up the fat layer floating on top.
Partial purification of an eIF2␣ kinase from this mouse liver supernatant was carried out through the following steps: ammonium sulfate fractionation (from 20 to 60% saturation), DEAE-cellulose chromatography, Mono Q HR 5/5 chromatography, and heparin-Sepharose chromatography. An eIF2␣ kinase activity was retained in all three columns and was eluted with 250, 300, and 100 mM KCl, respectively. Subsequently, the pooled material was loaded onto an affinity column made by coupling the eIF2 peptide to a Sulfolink ® gel (Pierce). The kinase activity was retained in this column and eluted with 500 mM KCl. After desalting, the sample was loaded onto an ATP-Sepharose column, where the kinase activity was not retained. This fraction was used for immunoprecipitation assays. Finally, this fraction was concentrated; layered onto 15-50% glycerol linear density gradients made in a buffer of 20 mM Hepes/KOH (pH 7.6), 100 mM KCl, 0.5 mM dithiothreitol, and 2 mM EDTA; and centrifuged for 67 h at 191,000 ϫ g. A gradient containing protein standards was run in parallel. The main peak of eIF2␣ kinase activity was pooled and kept frozen at Ϫ70°C until used.
Screening of a Mouse Liver cDNA Library-A mouse liver cDNA library in Zap (Stratagene) was screened as described (8) . The PstI fragment of the rat HRI cDNA obtained from Dr. L. S. Jefferson (15) was used as a probe. After successive rounds of screening, a positive plaque was purified. The cDNA insert was sequenced across both strands using an ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction kit (Perkin-Elmer).
Antibodies against a Synthetic mHRI Peptide-Based on the mHRI cDNA coding sequence, a synthetic peptide (CG-VDGERDTDDDA) was made, corresponding to amino acids 7-17, with two additional residues (CG) at its NH 2 -terminal end. The peptide was synthesized as described (8) and was coupled by the terminal cysteine residue to keyhole limpet hemocyanin (Calbiochem), and rabbits were immunized as described (19) . Serum was purified by affinity chromatography as described (8) . For simplicity, these affinity-purified anti-mHRI peptide antibodies will be referred to as anti-mHRI antibodies.
Construction of Plasmids-The coding sequence corresponding to mHRI was amplified by PCR using the cDNA cloned into the plasmid pBluescript SK (Stratagene) as a template. PCR oligonucleotides generated NcoI and EcoRI sites that allowed subcloning into pRSETB vector (Invitrogen) to generate pRSETB-MHRI for prokaryotic expression of recombinant mHRI polyhistidine-tagged under the control of the T7 promoter. For the expression of mHRI in mammalian cells under the control of a cytomegalovirus promoter, the PCR oligonucleotides generated EcoRI and XbaI sites, and the mHRI coding region was subcloned into pcDNA3.1/Myc-His vector (Invitrogen) in frame with a COOHterminal tag encoding the Myc epitope and a polyhistidine metal-binding peptide (pcMHRI-WT). Lys-196 was mutated to Arg by changing the Lys-196 AAG codon to AGG using the QuickChange TM site-directed mutagenesis kit (Stratagene), generating pcMHRI-K196R. The cDNAs encoding human wild-type eIF2␣ and the eIF2␣-S51A mutant in pRc/ CMV vectors (kindly provided by Dr. N. Sonenberg) were PCR-amplified and subcloned into pRSETB vectors (NcoI and EcoRI sites) for prokaryotic expression (pReIF2␣-WT and pReIF2␣-S51A).
Prokaryotic Expression of mHRI-The pRSETB-MHRI plasmid was used to transform competent BL21(DE3) cells (Stratagene). A culture of these cells (A 600 ϭ 0.6 -1) was incubated for 2.5-3 h with 0.5 mM isopropyl-␤-D-thiogalactopyranoside, and the cells were collected. The cell pellet was resuspended in lysis buffer (50 mM phosphate buffer (pH 8.0), 1 mM EDTA, 1% Triton X-100, and 0.1 mg/ml lysozyme) and incubated for 15 min at 30°C. The lysate was clarified by centrifugation at 15,000 ϫ g for 15 min at 4°C. The histidine tag in the recombinant protein allowed one-step affinity purification on a TALON TM metal affinity resin (CLONTECH). The column was first washed with 10 mM imidazole, and the recombinant enzyme was eluted with 50 mM imidazole. The same procedure was used for pReIF2␣-WT and pReIF2␣-S51A purification.
In Vitro Transcription and Translation of mHRI cDNA-Plasmids pcMHRI-WT and pcMHRI-K196R were translated in the TnT-coupled rabbit reticulocyte lysate transcription/translation system (Promega), according to the manufacturer's instructions, in the presence of 35 Slabeled methionine (Amersham Pharmacia Biotech). Aliquots of the reaction were immunoprecipitated with anti-mHRI antibodies and subjected to electrophoresis on 10% SDS-polyacrylamide gels. After Coomassie Blue staining, the gels were analyzed by fluorography.
Immunoprecipitation and eIF2␣ Kinase Assay-The immunoprecipitation of different samples containing mHRI with protein A-Sepharosebound anti-mHRI antibodies was as described previously (19) . Both purified mHRI and immune complexes were assayed for their ability to phosphorylate eIF2␣. The eIF2␣ phosphorylation assay was carried out as previously reported (19) . Labeled polypeptides were analyzed by both SDS-PAGE (20) on a 10% polyacrylamide gel (38.5:1 (w/v) acrylamide/ bisacrylamide) and autoradiography using Agfa Curix RP2 film and an Ilford intensifying screen. The areas corresponding to the phosphorylated ␣-subunit of eIF2 were scanned at 633 nm in a computing 300 A densitometer (Molecular Dynamics, Inc.).
Cell Cultures, Transient Transfection, and Liver Perfusion-NIH 3T3 cells or 293 fibroblasts were grown in Dulbecco's modified Eagle's medium containing 10% (v/v) fetal calf serum. NIH 3T3 cells were washed twice with ice-cold phosphate-buffered saline before lysis. For transfection, 293 cells were grown in 100-mm dishes until they reached 50 -60% confluence. Plasmids pcMHRI-WT and pcMHRI-K196R (5 g/dish) were transfected by the calcium phosphate method (21) . Mouse livers from BALB/c mice were perfused, as described previously (22) , with phosphate-buffered saline to remove the blood.
Affinity Purification, Phosphatase Assay, and Immunoblotting-At 36 h post-transfection, cells were washed twice with phosphate-buffered saline and lysed in 1 ml/dish of lysis buffer (20 mM Tris-HCl (pH 8.0), 200 mM NaCl, 5% (v/v) glycerol, 1% (v/v) Nonidet P-40, 0.2 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 10 g/ml aprotinin, 20 g/ml DNase, and 20 g/ml RNase) for 30 min at 4°C. The protein lysates were centrifuged at 15,000 ϫ g for 15 min at 4°C, and the supernatants were incubated with 20 l of TALON TM metal affinity resin for 20 min at 4°C. The resin was washed four times with lysis buffer containing 10 mM imidazole and twice with washing buffer (20 mM Tris-HCl (pH 8.0) and 5% (v/v) glycerol) before elution with washing buffer containing 100 mM imidazole. In some cases, the resin-bound proteins were incubated in dephosphorylation buffer (50 mM Tris-HCl (pH 8.5) and 0.1 mM EDTA) for 2 h at 37°C with or without 5 units of alkaline phosphatase (Boehringer Mannheim) just before an additional wash and elution. Eluted proteins were assayed for their ability to phosphorylate eIF2␣ or were resolved by electrophoresis, transferred to an Immobilon-P membrane (Millipore Corp.), and immunodetected using anti-Myc monoclonal antibodies (Invitrogen).
Isolation of mRNA and Northern Blot Hybridization-Total RNA from mouse liver or NIH 3T3 fibroblasts was obtained using a guanidine-based one-step method (23) . Poly(A) ϩ RNA was prepared from total RNA using a PolyAtract ® mRNA isolation system IV kit (Promega). Two g of poly(A)
ϩ RNA from each sample were separated on a formaldehyde-agarose gel and transferred to a nylon membrane as described (24) . This membrane was probed with the mHRI cDNA radiolabeled with [␣-32 P]dCTP (Amersham Pharmacia Biotech) and analyzed by autoradiography. The cDNA probe was then removed to allow reprobing with mouse ␤-actin cDNA (CLONTECH) as a quantity control probe and with mouse ␤-globin major gene cDNA (erythroid-specific probe) corresponding to the IMAGE consortium clone 349672 (GenBank TM accession number W30207) as a control of blood contamination.
Quantitative RT-PCR-Total RNA was isolated by the SV total RNA isolation system (Promega). RT-PCR was performed by the Access RT-PCR system (Promega) using 1 g of total RNA/50-l reaction. All the RNA samples were tested for genomic DNA contamination running control reactions without reverse transcriptase. The mHRI-specific primers were 5Ј-TGAGCCATGTGCACGAGCCAA (forward) and 5Ј-CT-TCCTGCTCCGACAGCACTT (reverse). To assess degradation of the RNA sample and to allow a quantitative comparison, aldolase A was chosen as the co-amplified internal standard of the RT-PCR assay. The aldolase A-specific primers were 5Ј-GACCCCGGAGCAGAAGAAG-GAGCTG (forward) and 5Ј-TTATACTGGGCACAGCGTTCAGACA (reverse). After optimization of RNA, Mg 2ϩ , and primer concentrations, the samples were subjected to different cycle numbers. The optimal number of cycles to produce linear amplification was determined to be 18 cycles. Data for mHRI mRNA expression levels were obtained by RT-PCR amplification of RNA samples from different mouse tissues. PCR products were detected by Southern hybridization to oligonucleotide-specific probes for mHRI and aldolase A, and the amount of hybridization was quantitated by PhosphorImager scanning.
Isolation of mHRI from NIH 3T3 Cell Extracts-NIH 3T3 cells were lysed with detergent buffer (50 mM Tris-HCl (pH 8.0), 10% glycerol, 1% Nonidet P-40, 0.2 mM phenylmethylsulfonyl fluoride, and a protease inhibitor mixture (Complete TM , Boehringer Mannheim)). Insoluble material was removed by centrifugation, and the supernatant was fractionated by ammonium sulfate precipitation (from 20 to 60% saturation), after which the precipitate was resuspended in buffer A (20 mM Tris-HCl (pH 7.6), 5% glycerol, 0.1 mM EDTA, 10 mM KCl, and 1 mM dithiothreitol). After desalting, the sample was loaded onto a Hi Trap heparin column (Amersham Pharmacia Biotech) equilibrated in buffer A, where the eIF2␣ kinase activity was retained, and subsequently eluted with 150 mM KCl. The sample was concentrated (Centricon 30, Amicon, Inc.) and assayed for its ability to phosphorylate eIF2␣.
RESULTS

Purification and Characterization of an eIF2␣
Kinase Activity from Mouse Liver Extracts-To characterize novel mammalian eIF2␣ kinases in nonerythroid cells, we have obtained a preparation containing an eIF2␣ kinase activity from postmitochondrial supernatants of mouse liver extracts with significant purity. Briefly, the method involved ammonium sulfate fractionation along with various ion-exchange and affinity chromatographies as described under "Experimental Procedures." The sample eluting from the ATP-Sepharose column was finally purified by glycerol gradient centrifugation. A single peak of eIF2␣ kinase activity sedimented in the molecular mass range of 90,000 Da (data not shown).
We studied the effect of hemin on the eIF2␣ kinase activity of the purified preparation. As a control, heme-reversible reticulocyte HRI (18) was assayed (Fig. 1A, lanes 1-6) . The mouse liver eIF2␣ kinase activity was also hemin-sensitive (Fig. 1A,  lanes 7-12) , and interestingly, both mouse and rabbit eIF2␣ kinase activities were inhibited by the same concentration range of hemin (Fig. 1B) . Note that the addition of hemin also inhibited phosphorylation of reticulocyte HRI itself (Fig. 1A,  lanes 1-6) (18) . Similarly, a phosphopolypeptide with the same mobility as phosphorylated HRI on SDS-PAGE was sensitive to hemin, whereas phosphorylation of a lower molecular mass contaminating polypeptide was not affected in the mouse liver preparations (Fig. 1A, lanes 7-12) . Furthermore, affinity-purified antibodies, raised against a synthetic peptide based on the predicted mHRI sequence, specifically immunoprecipitated this phosphopolypeptide (see below). These results strongly suggest that this phosphoprotein corresponds to phosphorylated mHRI. All together, our results indicate that mouse liver extracts contain a heme-sensitive eIF2␣ kinase (mHRI) that also undergoes phosphorylation inhibited by hemin.
Isolation of mHRI cDNA-Because the purified mouse liver eIF2␣ kinase activity was heme-sensitive, we tested whether this activity could correspond to an HRI homologue. We studied the possible expression of an HRI mRNA in mouse liver by Northern blot analysis of poly(A) ϩ RNA using the rat HRI cDNA (15) as a probe, resulting in the presence of a single 2.9-kilobase transcript (data not shown). This result suggested the presence of an HRI mRNA in mouse liver. Because of this, a rat HRI cDNA probe was used for searching for an HRI homologue in a mouse liver cDNA library. Among the positive clones obtained, one positive plaque (clone pMHRI) was purified, excised into pBluescript SK Ϫ , and sequenced. This clone contains a cDNA insert of 2768 base pairs. The nucleotide analysis of this clone revealed 212 nucleotides preceding the first ATG codon and then an open reading frame of 1857 base pairs (nucleotides 213-2069), followed by 699 base pairs of a 3Ј-noncoding region. Thus, this clone represents a full-length mHRI cDNA. The cDNA encodes for a protein of 619 amino acids ( Fig. 2) with a predicted molecular mass of 69.7 kDa. The amino acid sequence deduced from the mouse cDNA clone contains the 12 conserved catalytic subdomains of Ser/Thr protein kinases (Fig. 2) . It is interesting that mHRI and these two other HRIs possess two conserved heme regulatory motifs (Fig.  2) , which are also found in other heme-binding proteins (5, 11) . Comparison of the amino acid sequences of mHRI with those of rat brain and rabbit reticulocyte HRIs displayed 94 and 83% overall amino acid sequence identities, respectively, and it is FIG. 1. Characterization of a purified eIF2␣ kinase activity from mouse liver extracts. A, shown are the effects of hemin on the purified mouse liver eIF2␣ kinase activity. Samples of either purified HRI from rabbit reticulocyte lysates, as a control (lanes 1-6) , or purified eIF2␣ kinase from mouse liver extracts (lanes 7-12) were incubated for 10 min at 30°C with increasing concentrations of hemin as indicated. All samples were analyzed for their ability to phosphorylate rabbit eIF2␣, followed by SDS-PAGE on 10% gels and autoradiography. The positions of phosphorylated eIF2␣ and HRI are indicated. B, the amount of eIF2␣ phosphorylation was estimated by quantifying the corresponding band density of the autoradiogram in A as described under "Experimental Procedures." Ⅺ, reticulocyte HRI; ࡗ, mHRI.
notable that the greatest variation is concentrated in the unique insertion sequence of ϳ140 amino acids located between catalytic subdomains IV and V (Fig. 2) . All these data indicate that the mHRI cDNA encodes a novel HRI family member.
Characterization of mHRI cDNA-To determine if the mouse liver eIF2␣ kinase corresponds to the polypeptide encoded by the mHRI cDNA, we immunoprecipitated the enzyme from purified mouse liver extracts using an anti-mHRI antibody raised against a specific peptide of the deduced mHRI amino acid sequence, followed by an eIF2␣ kinase assay. As a control, reticulocyte HRI was immunoprecipitated from rabbit reticulocyte lysates using specific anti-HRI antibodies (19) to determine the respective mobilities of phosphorylated HRI and eIF2␣ in SDS-PAGE (Fig. 3A, lane 5) . A major labeled polypeptide, with the same molecular mass as phosphorylated HRI, was produced by mHRI immune complexes (Fig. 3A, lane 1) , and moreover, the isolated immune complexes specifically phosphorylated the ␣-subunit of purified rabbit reticulocyte eIF2 (lane 2).
In addition, we expressed the mHRI clone as a histidinetagged fusion protein in a prokaryotic expression system as described under "Experimental Procedures." The recombinant enzyme underwent phosphorylation (Fig. 3A, lane 3) and was fully active in phosphorylating eIF2␣ (lane 4), and both activities were specifically immunoprecipitated by the anti-mHRI antibodies. The observed phosphorylation of recombinant mHRI indicates that it is due to an autokinase reaction. Affin- ity-purified recombinant mHRI was also hemin-sensitive (Fig.  3B) . Thus, both the autokinase and eIF2␣ kinase activities were inhibited by low concentrations of hemin. Of greater interest was the finding that recombinant mHRI specifically phosphorylated eIF2␣ at Ser-51 (Fig. 3C) . We therefore conclude that the purified mHRI from mouse liver extracts and recombinant mHRI are the same protein, that both are active as autokinase and as eIF2␣ kinase, and that these activities are regulated in vitro by low concentrations of hemin.
In Vivo Phosphorylation of Recombinant mHRI-Plasmids pcMHRI-WT and pcMHRI-K196R, encoding wild-type mHRI and the inactive mHRI mutant, respectively, were expressed in 293 cells, and the affinity-purified proteins were analyzed by SDS-PAGE and immunoblotting as described under "Experimental Procedures." We found a slower mobility of wild-type mHRI (Fig. 4A, lane 4) compared with inactive mHRI-K196R (lane 3). However, when these plasmids were transcribed and translated in the TnT-coupled reticulocyte lysate system, both yielded a single product of ϳ76 kDa, specifically immunoprecipitated by the anti-mHRI antibodies (Fig. 4A, lanes 1 and 2) , with the same electrophoretic mobility as that observed for the in vivo expressed mHRI-K196R protein and in good agreement with the value predicted from the mHRI cDNA nucleotide sequence.
Recently, it has been reported that wild-type PKR, but not the inactive PKR-K296R mutant, is autophosphorylated and that the active phosphorylated form of PKR migrates slower in SDS-PAGE (25, 26) . Therefore, to determine if the mobility differences between the mutant and wild-type mHRI proteins were attributed to an in vivo autophosphorylation of wild-type mHRI, we treated the samples with alkaline phosphatase prior to gel electrophoresis and immunoblotting. The data presented in Fig. 4B demonstrate that, indeed, the phosphatase treatment increased the mobility of wild-type mHRI and caused its co-migration with mHRI-K196R. As expected, wild-type mHRI, but not the inactive mHRI-K196R mutant, expressed in 293 cells, specifically phosphorylated the ␣-subunit of purified reticulocyte eIF2 (Fig. 4C, lanes 3 and 4) . These results support the idea that mHRI expressed in mammalian cells has an autokinase activity in vivo.
Expression of mHRI mRNA in Nonerythroid Tissues-The expression of mHRI mRNA in various mouse tissues was analyzed by Northern blotting of poly(A) ϩ RNA with a full-length cDNA as a probe. A single 2.9-kilobase mRNA that hybridized to the mHRI cDNA was detected in all tissues examined (data not shown), suggesting that mHRI may be expressed ubiquitously. For a better quantitation of the expression of mHRI mRNA in these tissues, we performed RT-PCR as described under "Experimental Procedures." We found that within carefully checked experimental limits, the starting material could be quantified. The amount of mHRI transcript varied greatly, and a rough classification can be made as follows: group 1 (70 -100%), liver and spleen; group 2 (10 -20%), kidney, testis, brain, and lung; group 3 (2-3%), heart; and group 4 (Ͻ0.01%), skeletal muscle (Table I ). In summary, we detected an mHRIspecific transcript in all nonerythroid tissues examined, although there are significant differences in the expression levels of mHRI mRNA among them.
By using a mouse ␤-globin probe, we detected a very low amount of globin mRNA in our mouse liver preparations compared with reticulocytes (data not shown), and it was completely removed when the tissue was perfused prior to extraction of RNA (Fig. 5A) . Of greater interest was the finding that the amount of mHRI mRNA was approximately equal in both the untreated and perfused mouse livers (Fig. 5A ). This result confirmed that the mHRI mRNA signal in the nonerythroid samples was not due to contamination with reticulocyte HRI mRNA.
Expression and Activity of mHRI in NIH 3T3 Cells-In an attempt to support the notion that HRI mRNA is expressed in FIG. 3 . A, autokinase and eIF2␣ kinase activities of both purified and recombinant mHRIs. Shown are the results from the in vitro phosphorylation of purified rabbit reticulocyte eIF2 by immune complexes prepared from either purified mHRI (lanes 1 and 2) or purified recombinant mHRI as described under "Experimental Procedures" (lanes 3 and 4) , using anti-mHRI antibodies, and by rabbit reticulocyte lysates (RRL) (lane 5), as a control, using anti-HRI antibodies (19), as described under "Experimental Procedures." In lanes 1 and 3, the addition of eIF2 was omitted. The positions of phosphorylated HRI, mHRI, recombinant mHRI (His-mHRI), and eIF2␣ are indicated. B, the effect of hemin on the autokinase and eIF2␣ kinase activities of recombinant mHRI. Samples of purified recombinant mHRI were incubated with increasing concentrations of hemin as indicated. All samples were assayed as described for Fig. 1A , although in this case, wild-type human eIF2␣ purified from Escherichia coli, as described under "Experimental Procedures," was used as substrate. The positions of phosphorylated His-mHRI and eIF2␣ are indicated. C, recombinant mHRI specifically phosphorylates the ␣-subunit of eIF2 at Ser-51. In vitro kinase reactions contained either no kinase (lanes 1 and 3) or recombinant mHRI (lanes 2 and 4) . The reactions also included wild-type (wt) human eIF2␣ (lanes 1 and 2) or eIF2␣-S51A ( lanes 3 and 4) purified from E. coli as described under "Experimental Procedures." The position of eIF2␣ is indicated.
nonerythroid cells, we investigated the presence of mHRI mRNA in NIH 3T3 cells. The data presented in Fig. 5A show that mHRI mRNA was also expressed in NIH 3T3 cells. Furthermore, we detected the presence of an eIF2␣ kinase activity in partially purified NIH 3T3 cell extracts (Fig. 5B, lanes 1 and  2) , which was totally inhibited by low concentrations of hemin (lanes 3-5) . These results confirm the presence of HRI-like enzymes in a broad range of tissues and cells.
DISCUSSION
In this study, we have partially purified an eIF2␣ kinase (mHRI) activity from either mouse liver or NIH 3T3 cell extracts. It is especially important to note that this novel eIF2␣ kinase activity is responsive to hemin, in marked contrast to PKR and GCN2. Although HRI was previously cloned from rat brain (15) and it was demonstrated that the rat HRI mRNA is expressed in a wide variety of nonerythroid tissues, until now, there was no evidence of HRI activity in such tissues. In fact, it has been suggested that HRI may be an erythroid-specific enzyme (5). Our findings lead to the notion that an HRI activity exists in nonerythroid tissues and cell cultures and raise the possibility of additional roles for this enzyme in translational regulation. We have cloned the cDNA encoding this mouse liver eIF2␣ kinase homologue of rabbit reticulocyte HRI. We show here that the expression of wild-type mHRI in a prokaryotic system yields a protein with characteristics indistinguishable from those of mHRI purified from mouse liver extracts. Thus, purified and recombinant mHRIs are specifically recognized by anti-mHRI antibodies and exhibit both autokinase and eIF2␣ kinase activities that are inhibited by heme in vitro. Similar results have been previously obtained with recombinant reticulocyte HRI expressed in insect cells (27) , but not with recombinant rat HRI expressed in a prokaryotic system, where no autophosphorylating activity was detected (5) .
There is evidence that autophosphorylation is required for the activation of PKR (28) and that wild-type PKR, but not the inactive PKR-K296R mutant, undergoes autophosphorylation when expressed in yeast cells (25) . Accordingly, recombinant mHRI specifically phosphorylates eIF2␣ in vitro at Ser-51, and moreover, wild-type mHRI, but not the inactive mHRI-K196R mutant, expressed in 293 cells, has shown an autophosphoryl- ϩ RNA prepared from either untreated or perfused mouse liver and from NIH 3T3 cells were separated on a formaldehydeagarose gel, transferred to a nylon membrane, and hybridized with the mHRI cDNA (top panel) as described under "Experimental Procedures." The membrane was then stripped of the probe and rehybridized to a ␤-globin cDNA probe (middle panel). To check RNA levels, the same blot was subsequently rehybridized with a mouse actin gene probe (bottom panel). B, shown are the results from the in vitro phosphorylation of eIF2␣ by partially purified mHRI from NIH 3T3 cell extracts in the absence (lanes 1 and 2) or presence (lanes 3-5) of the indicated increasing concentrations of hemin, as described under "Experimental Procedures." In lane 1, the addition of rabbit eIF2 was omitted. All samples were analyzed as described for Fig. 1A . The position of phosphorylated eIF2␣ is indicated. 1 and 2) . Affinity-purified wild-type mHRI or mHRI-K196R from 293 cells was subjected to electrophoresis and immunoblot analysis with anti-Myc monoclonal antibodies (lanes 3 and 4) . B, affinity-purified wild-type mHRI or mHRI-K196R from 293 cells was incubated with (lanes 2 and 4) or without (lanes 1 and 3) alkaline phosphatase (AP) before gel electrophoresis and immunoblot analysis for comparison of relative mobilities. The phosphorylated form of mHRI (mHRI*) migrated slower than the unphosphorylated form (mHRI), as indicated. C, shown are the results from the in vitro phosphorylation of purified rabbit eIF2 by purified HRI from rabbit reticulocyte lysates (lane 1), as a control, and by affinity-purified proteins from cells transfected with plasmids pcMHRI-WT and pcMHRI-K196R (lanes 3 and 4) or with an empty vector (lane 2) as described under "Experimental Procedures." The position of eIF2␣ is indicated.
ating activity in vivo. It has recently been shown that Thr-446 and Thr-551 in the PKR activation loop are some autophosphorylation sites in vivo (26) , and it is of interest that mHRI contains two Thr residues (Thr-485 and Thr-490) at exactly the same positions relative to subdomain VIII as those occupied by Thr-446 and Thr-551 in PKR. In summary, we have cloned and purified a mouse eIF2␣ kinase from nonerythroid cells, showing all the properties that are characteristic of reticulocyte HRI.
We have provided evidence that the mRNA encoding this enzyme is expressed in all mouse tissues examined as well as in NIH 3T3 cells. In addition, consistent with the Northern analysis (data not shown), the quantitative RT-PCR assays (applied to total unfractionated RNA) revealed a broad range of expression levels of mHRI mRNA in every tissue investigated. Thus, we have found a strong expression in liver, kidney, and testis and at least 3 orders of magnitude less in skeletal muscle. The general abundance of mHRI mRNA in mouse nonerythroid tissues, together with the presence of a heme-sensitive eIF2␣ kinase activity in both liver and NIH 3T3 cell extracts, may indicate that HRI plays additional roles in mammalian cells. It will now be important to establish alternative mechanisms of regulation of HRI in cells that do not produce significant levels of hemin. In this respect, we have isolated and partially purified, from mouse liver post-mitochondrial supernatants, an eIF2␣ kinase inhibitor that could be involved in the translational control of mammalian liver. 2 Collectively, our results indicate that mHRI is an eIF2␣ kinase that occurs in nonerythroid cells. The main physiological function of HRI in erythroid cells appears to be the balanced synthesis of globin chains and heme, whereas the physiological significance of the expression of HRI in nonerythroid cell types remains to be clarified. Control of the activity of eIF2␣-specific kinases occurs in response to stimulation of cell proliferation by mitogens and growth factors as well as to induction of cell differentiation (11, 12) . Other studies have suggested that PKR may function as a suppressor of cell proliferation and tumorigenesis (29, 30) . However, more recently, Yang et al. (31) reported that mice devoid of functional PKR develop normally, suggesting that this enzyme does not play an essential role in growth control, either because this is not its function or because it is redundant in this regard. The presence of another eIF2␣ kinase in mouse cells, reported here, could explain such results by assuming that mHRI can replace PKR functionally in PKR knockout mice. Thus, our finding that mHRI undergoes autophosphorylation when expressed in mammalian cells strongly suggests that HRI, like PKR, is an ubiquitous mammalian eIF2␣ kinase and raises the possibility that these enzyme may also play a role in the growth and differentiation of nonerythroid cells.
